| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia
2 From Sleep Disorders Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia
Patients with cystic fibrosis (CF) often hypoventilate during sleep with marked falls in oxygen saturation (SaO2%). This occurs most commonly during REM sleep, when there is a reduction in rib cage excursion and a fall in end-expiratory lung volume (EELV). The aim of this study was to examine the effect of nocturnal nasal continuous positive airway pressure (nCPAP) on SaO2 and the respiratory disturbance index (RDI) during sleep in patients with CF and severe lung disease. Seven patients (FEV1% pred, 23 ± 5; range, 14 to 28%) were evaluated during sleep on two nights, control and nCPAP (11 ± 2 cm H2O; range, 8 to 16 cm H2O), with four patients breathing room air and three patients breathing suplemental oxygen on both nights. Mean awake SaO2 was 91 ± 1% (range, 89 to 93%). All patients showed significant oxyhemoglobin desaturation and respiratory disturbance in the control study. The maximal falls in SaO2 (15 ± 10%) were most often associated with phasic eye movements, and a decline in rib cage excursion and the sum signal (Respitrace) during REM sleep. Nasal CPAP resulted in a significant improvement in the mean minimum oxygen saturation (MMOS) during both NREM (nCPAP 91 ± 3% vs control 88 ± 2%, p<0.05) and REM sleep (nCPAP 89 ± 6% vs control 83 ± 6%, p<0.05). Transcutaneous CO2 measurements were not significantly different between the control and the nCPAP studies. The RDI was also significantly reduced with nCPAP especially during REM sleep (9±7 events per hour vs control 25 ± 11 events per hour, p<0.05). Nasal CPAP caused no change in total sleep time or sleep efficiency yet significantly reduced the RDI and improved baseline SaO2 during both NREM and REM sleep.
Key Words: cystic fibrosis • nCPAP • sleep-disordered breathing
Submitted on February 2, 1993
Accepted on June 28, 1994
This article has been cited by other articles:
|
|
 |
|
  B. Fauroux, F. Nicot, S. Essouri, N. Hart, A. Clement, M.I. Polkey, and F. Lofaso Setting of noninvasive pressure support in young patients with cystic fibrosis Eur. Respir. J., October 1, 2004; 24(4): 624 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Milross, A. J. Piper, M. Norman, G. N. Willson, R. R. Grunstein, C. E. Sullivan, and P. T. P. Bye Predicting Sleep-Disordered Breathing in Patients With Cystic Fibrosis Chest, October 1, 2001; 120(4): 1239 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. MILROSS, A. J. PIPER, M. NORMAN, H. F. BECKER, G. N. WILLSON, R. R. GRUNSTEIN, C. E. SULLIVAN, and P. T. P. BYE Low-flow Oxygen and Bilevel Ventilatory Support . Effects on Ventilation during Sleep in Cystic Fibrosis Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 129 - 134. [Abstract] [Full Text]
|
|
|
|
 |
|
 M P Villa, J Pagani, V Lucidi, S Palamides, and R Ronchetti Nocturnal oximetry in infants with cystic fibrosis Arch. Dis. Child., January 1, 2001; 84(1): 50 - 54. [Abstract] [Full Text]
|
|
|
|
|
|
S. Bradley, P. Solin, J. Wilson, D. Johns, E. H. Walters, and M. T. Naughton Hypoxemia and Hypercapnia During Exercise and Sleep in Patients With Cystic Fibrosis Chest, September 1, 1999; 116(3): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fauroux, M. Boulé, F. Lofaso, F. Zérah, A. Clément, A. Harf, and D. Isabey Chest Physiotherapy in Cystic Fibrosis: Improved Tolerance With Nasal Pressure Support Ventilation Pediatrics, March 1, 1999; 103(3): 32e - 32. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
